Viewing Study NCT05359432


Ignite Creation Date: 2025-12-24 @ 10:00 PM
Ignite Modification Date: 2026-01-02 @ 3:38 AM
Study NCT ID: NCT05359432
Status: COMPLETED
Last Update Posted: 2022-05-03
First Post: 2022-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes Mellitus
Sponsor: Getz Pharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module